Literature DB >> 16396700

Prevalence of musculoskeletal conditions in an Italian population sample: results of a regional community-based study. I. The MAPPING study.

F Salaffi1, R De Angelis, W Grassi.   

Abstract

OBJECTIVE: The objective of the MAPPING study was to estimate the prevalence of musculoskeletal conditions in an Italian population sample.
METHODS: Questionnaires were sent to a random sample of 3664 individuals aged 18 years and over, stratified for age and gender, selected from the practice lists of 16 general practices. Trained rheumatologists carried out structured visits in which subjects were asked about musculoskeletal symptoms and socio-demographic characteristics, and underwent a standardized physical examination. Cases were defined by previously validated criteria.
RESULTS: A total of 2155 subjects participated in the study (response rate 58.8%). The overall prevalence of musculoskeletal conditions in the general adult population was 26.7% (95% CI 25.4-28.5), being significantly higher among women than men (p < 0.0001). Disease prevalence increased significantly with age (p < 0.0001). The most common disease group was symptomatic peripheral osteoarthritis (SPOA), with a prevalence of 8.95% (95% CI 6.81-10.7), followed by soft tissue disorders--STD (8.81%; 95% CI 7.16-10.29), low back pain--LBP (5.91%; 95% CI 4.89-6.89), and inflammatory rheumatic disease--IRD (3.06%; 95% CI 2.38-3.93). The estimated rates of disease prevalence were as follows: rheumatoid arthritis: 0.46% (95% CI 0.33-0.59); psoriatic arthritis: 0.42% (95% CI 0.31-0.61); ankylosing spondylitis: 0.37% (95% CI 0.23-0.49); polymyalgia rheumatica: 0.37% (95% CI 0.29-0.44); undifferentiated connective tissue disease: 0.14% (95% CI 0.09-0.21); crystal arthropathies, including gout 0.46% (95% CI 0.34-0.57) and chondrocalcinosis: 0.42% (95% CI 0.33-0.58); symptomatic knee osteoarthritis (OA): 5.39% (95% CI 3.41-7.99); hip-OA: 1.61% (95% CI 1.39-1.87); hand-OA: 1.95 (95% CI 1.22-2.48); fibromyalgia: 2.22% (95% CI 1.36-3.19); shoulder tendinitis/adhesive capsulitis: 3.06% (95% CI 2.11-4.09); carpal tunnel syndrome: 1.90% (95% CI 1.06-2.29), localized regional pain syndromes of the neck: 0.88% (95% CI 0.561.29), and lateral epicondylitis 0.74% (95% CI 0.47-1.33).
CONCLUSIONS: The MAPPING study indicates that musculoskeletal conditions are common in the general adult population of Italy. These data are useful in planning the provision of healthcare.

Entities:  

Mesh:

Year:  2005        PMID: 16396700

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  99 in total

1.  [Trigger points - Diagnosis and treatment concepts with special reference to extracorporeal shockwaves].

Authors:  M Gleitz; K Hornig
Journal:  Orthopade       Date:  2012-02       Impact factor: 1.087

Review 2.  Worldwide epidemiology of fibromyalgia.

Authors:  Luiz Paulo Queiroz
Journal:  Curr Pain Headache Rep       Date:  2013-08

3.  Mechanical pain sensitivity and the severity of chronic neck pain and disability are not modulated across the menstrual cycle.

Authors:  Jaclyn E Balter; Jennifer L Molner; Wendy M Kohrt; Katrina S Maluf
Journal:  J Pain       Date:  2013-09-07       Impact factor: 5.820

4.  Osteoarthritis: a holistic approach.

Authors:  Andrew Barr; Philip G Conaghan
Journal:  Clin Med (Lond)       Date:  2012-04       Impact factor: 2.659

5.  The burden of disease in rheumatoid arthritis.

Authors:  Till Uhlig; Rikke H Moe; Tore K Kvien
Journal:  Pharmacoeconomics       Date:  2014-09       Impact factor: 4.981

6.  Cost-effectiveness treatment with Rituximab in patients with rheumatoid arthritis in real life.

Authors:  Maurizio Benucci; Gianantonio Saviola; Paola Baiardi; Mariangela Manfredi
Journal:  Rheumatol Int       Date:  2010-05-16       Impact factor: 2.631

Review 7.  Fibromyalgia and nutrition, what do we know?

Authors:  Laura-Isabel Arranz; Miguel-Angel Canela; Magda Rafecas
Journal:  Rheumatol Int       Date:  2010-04-01       Impact factor: 2.631

8.  Cost-Effectiveness Analysis of Lesinurad/Allopurinol Versus Febuxostat for the Management of Gout/Hyperuricemia in Italy.

Authors:  M Ruggeri; M Basile; C Drago; F R Rolli; A Cicchetti
Journal:  Pharmacoeconomics       Date:  2018-05       Impact factor: 4.981

Review 9.  [Chondrocalcinosis due to calcium pyrophosphate deposition (CPPD). From incidental radiographic findings to CPPD crystal arthritis].

Authors:  A-K Tausche; M Aringer
Journal:  Z Rheumatol       Date:  2014-05       Impact factor: 1.372

Review 10.  Are spondyloarthropathies as common as rheumatoid arthritis worldwide? A review.

Authors:  Nurullah Akkoc
Journal:  Curr Rheumatol Rep       Date:  2008-10       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.